Interview with Bruce E. Johnson, M.D., professor,
Harvard Medical School and Dana-Farber Cancer Institute; principal investigator, Lung Cancer SPORE
Dr. Johnson defines driver mutations of epidermal growth factor receptor (EGFR) in patients with lung cancer, the potential for treating these mutations with targeted agents and next steps for research on EGFR.
Download* the mp4 of the video (64.73 MB, 5:41 minutes)
*On a PC, right mouse click on the "Download" link and select "Save link as..." in Firefox or "Save Target as..." in Internet Explorer.
Page updated: April 5, 2011